00:31:42 Europe / Stockholm

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande


2023-10-27 Kvartalsrapport 2023-Q3
2023-07-21 Kvartalsrapport 2023-Q2
2023-04-27 Kvartalsrapport 2023-Q1
2023-03-21 Årsstämma 2023
2023-02-16 Bokslutskommuniké 2022
2022-10-27 Kvartalsrapport 2022-Q3
2022-07-22 Kvartalsrapport 2022-Q2
2022-04-28 Kvartalsrapport 2022-Q1
2022-03-16 Ordinarie utdelning OKDBV 0.04 EUR
2022-03-16 Ordinarie utdelning OKDAV 0.04 EUR
2022-03-15 Årsstämma 2022
2022-02-18 Bokslutskommuniké 2021
2021-10-27 Kvartalsrapport 2021-Q3
2021-07-20 Kvartalsrapport 2021-Q2
2021-04-27 Kvartalsrapport 2021-Q1
2021-03-17 Ordinarie utdelning OKDBV 0.03 EUR
2021-03-17 Ordinarie utdelning OKDAV 0.03 EUR
2021-03-16 Årsstämma 2021
2021-02-18 Bokslutskommuniké 2020
2020-10-23 Kvartalsrapport 2020-Q3
2020-07-17 Kvartalsrapport 2020-Q2
2020-04-24 Kvartalsrapport 2020-Q1
2020-03-18 Ordinarie utdelning OKDBV 0.09 EUR
2020-03-18 Ordinarie utdelning OKDAV 0.09 EUR
2020-03-17 Årsstämma 2020
2020-02-07 Bokslutskommuniké 2019
2019-07-17 Kvartalsrapport 2019-Q2
2019-03-20 Ordinarie utdelning OKDAV 0.09 EUR
2019-03-20 Ordinarie utdelning OKDBV 0.09 EUR
2019-03-19 Årsstämma 2019
2018-11-01 Kvartalsrapport 2018-Q3
2018-07-18 Kvartalsrapport 2018-Q2
2018-04-27 Kvartalsrapport 2018-Q1
2018-03-20 Ordinarie utdelning OKDBV 0.09 EUR
2018-03-20 Ordinarie utdelning OKDAV 0.09 EUR
2018-03-19 Årsstämma 2018
2018-02-13 Bokslutskommuniké 2017
2017-10-25 Kvartalsrapport 2017-Q3
2017-07-21 Kvartalsrapport 2017-Q2
2017-04-28 Kvartalsrapport 2017-Q1
2017-03-15 Ordinarie utdelning OKDAV 0.14 EUR
2017-03-15 Ordinarie utdelning OKDBV 0.14 EUR
2017-03-14 Årsstämma 2017
2017-02-13 Bokslutskommuniké 2016
2016-10-20 Kvartalsrapport 2016-Q3
2016-07-19 Kvartalsrapport 2016-Q2
2016-04-22 Kvartalsrapport 2016-Q1
2016-03-15 Ordinarie utdelning OKDBV 0.13 EUR
2016-03-15 Ordinarie utdelning OKDAV 0.13 EUR
2016-03-14 Årsstämma 2016
2016-02-05 Bokslutskommuniké 2015
2015-10-22 Kvartalsrapport 2015-Q3
2015-09-09 Kapitalmarknadsdag 2015
2015-07-17 Kvartalsrapport 2015-Q2
2015-04-23 Kvartalsrapport 2015-Q1
2015-03-31 Ordinarie utdelning OKDBV 0.00 EUR
2015-03-31 Ordinarie utdelning OKDAV 0.00 EUR
2015-03-30 Årsstämma 2015
2015-02-06 Bokslutskommuniké 2014
2014-10-23 Kvartalsrapport 2014-Q3
2014-07-24 Kvartalsrapport 2014-Q2
2014-04-24 Kvartalsrapport 2014-Q1
2014-03-25 Ordinarie utdelning OKDBV 0.00 EUR
2014-03-25 Ordinarie utdelning OKDAV 0.00 EUR
2014-03-24 Årsstämma 2014
2014-02-07 Bokslutskommuniké 2013
2013-10-24 Kvartalsrapport 2013-Q3
2013-07-25 Kvartalsrapport 2013-Q2
2013-04-25 Kvartalsrapport 2013-Q1
2013-03-21 Ordinarie utdelning OKDBV 0.09 EUR
2013-03-21 Ordinarie utdelning OKDAV 0.09 EUR
2013-03-20 Årsstämma 2013
2013-02-07 Bokslutskommuniké 2012
2012-10-25 Kvartalsrapport 2012-Q3
2012-07-26 Kvartalsrapport 2012-Q2
2012-04-26 Kvartalsrapport 2012-Q1
2012-03-27 Ordinarie utdelning OKDAV 0.08 EUR
2012-03-27 Ordinarie utdelning OKDBV 0.08 EUR
2012-03-26 Årsstämma 2012
2012-02-09 Bokslutskommuniké 2011
2011-10-27 Kvartalsrapport 2011-Q3
2011-08-04 Kvartalsrapport 2011-Q2
2011-04-07 Ordinarie utdelning
2011-04-07 Bonusutdelning
2011-04-07 Bonusutdelning
2011-04-07 Ordinarie utdelning
2010-04-08 Ordinarie utdelning
2010-04-08 Ordinarie utdelning
2009-04-17 Ordinarie utdelning
2009-04-17 Ordinarie utdelning
2008-03-18 Ordinarie utdelning
2008-03-18 Ordinarie utdelning
2007-03-14 Ordinarie utdelning
2007-03-14 Ordinarie utdelning


ListaMid Cap Helsinki
IndustriLäkemedel & Handel
Oriola är en läkemedelskoncern med särskilt fokus inom distribution av läkemedel till andra aktörer inom branschen. Bolaget erbjuder tjänster till apotek och övriga läkemedelsbolag, vilket exempelvis innefattar förhandlingar med leverantörer och distribution av produkter. Idag innehas störst verksamhet inom Norden och Baltikum. Huvudkontoret ligger i Esbo.
2022-05-16 09:00:00

Press release 16 May 2022

Oriola and Euroapotheca announce prospective CEO and Chairman of the Board for the planned pharmacy joint venture in Sweden

As announced on 9 February, Oriola and Euroapotheca have signed a framework merger agreement for combining the respective pharmacy businesses Kronans Apotek and Apoteksgruppen into a new company in Sweden.

Now the companies have indicatively agreed that current CEO of Apoteksgruppen Mr. Erik Sjögren will be the prospective CEO of the new company. Additionally, the parties have indicatively agreed that Oriola's Chairman of the Board Mr. Panu Routila will be the prospective Chairman of the Board of the new company and Ms. Katarina Gabrielson, the CEO of Oriola Corporation, would also be joining the Board. Euroapotheca will nominate its candidates to the Board in the due course.

The transaction is subject to competition authorities' approval

The new company to be established will have over 470 chain driven pharmacies, 44 franchise driven pharmacies and full online pharmacy operations, over 2,300 full-time employees and an illustrative combined revenue of EUR 1,140 million as of 2020 in Sweden. The new company will be the third largest player in the Swedish pharmacy market by revenue, with an estimated combined market share of 25 percent.

The transaction is subject to competition authorities' approval. The European Commission has already given its decision on a referral request made by the parties and decided to refer the case in its entirety to be reviewed and ultimately decided upon by the Swedish Competition Authority (Konkurrensverket).

Both parties are working in active dialogue with the relevant authorities. Approval of the transaction is expected to be received during the second half of 2022. Until all merger closing conditions are met and the merger is completed, both Kronans Apotek and Apoteksgruppen will continue to operate fully separately and independently.

Further information:

Tuula Lehto
VP, Communications and Sustainability, Oriola
tel. +358 40 5885 343
email: tuula.lehto@oriola.com

Laimonas Devyžis
Head of Business Development, Euroapotheca UAB
Email: Laimonas.devyzis@ev.lt

Oriola is a health and wellbeing company operating in Finland and Sweden. We help people to lead healthier lives by giving them access to sustainable health and wellbeing products and services. In Sweden, Oriola owns the country's third-largest pharmacy chain, Kronans Apotek. In addition to pharmacies, our dose-dispensing, medical information and patient support services enhance the safety and effectiveness of pharmaceutical care. Our expert services support pharmaceutical companies throughout the entire lifecycle of medicines. Oriola's supply chain ensures reliable and safe delivery of pharmaceuticals to pharmacies, hospital pharmacies, veterinarians and other healthcare operators. In 2021, Oriola's net sales were 1.9 billion euros and group employed approximately 4,100 professionals. Oriola Corporation is listed on Nasdaq Helsinki. www.oriola.com

EUROAPOTHECA is an international group of Northern European companies that operate retail pharmacy chains and wholesale pharmaceutical companies in Lithuania, Sweden, Latvia and Estonia, as well as online pharmacies in Lithuania, Latvia and Estonia. EUROAPOTHECA group was established in 1998. EUROAPOTHECA currently owns 480 pharmacies and 119 franchised pharmacies in four countries and employs more than 3900 employees. EUROAPOTHECA controls pharmacy chain Eurovaistinė (274 pharmacies) in Lithuania, Apoteksgruppen (150 pharmacies and 43 franchised pharmacies) in Sweden, Euroapteek (76 franchised pharmacies) in Estonia, Euroaptieka (56 pharmacies) in Latvia. www.euroapotheca.lt